I'm Mahboob Hasan, Founder and CEO of Cosmyra Technologies Private Limited.
Through Cosmyra, we're building AI-powered solutions to make quality healthcare affordable and accessible across India—starting with Doctrly, our platform for live doctor consultations, diagnostics, and more.
But my deeper obsession has always been the root of human decline: biological aging itself.
Watching loved ones lose vitality over time, I dove into epigenetics and the emerging science of partial reprogramming. Public research shows that transient activation of factors like OSK (Oct4, Sox2, Klf4) can reverse epigenetic markers of age in cells and animal models—without full dedifferentiation or major risks when precisely controlled.
“This isn't just theory anymore. Recent studies demonstrate rejuvenation of tissues, improved healthspan biomarkers, and even lifespan extension via targeted approaches.”
The Launch of EpochRevive
EpochRevive was born from this conviction: we can engineer escape velocity from the short biological horizons that limit human potential.
Right now, EpochRevive is an early-stage research initiative under the Cosmyra umbrella—no external funding, no formal team beyond initial exploration, no proprietary experiments yet. It starts with deep literature review, conceptual modeling, and planning for safe, responsible advancements in partial epigenetic reprogramming.
Our Commitment to the Future
We move deliberately: prioritizing safety (avoiding tumorigenesis risks highlighted in the field), reproducibility, open sharing of insights, and eventual equity in access.
If you're a researcher passionate about epigenetic rejuvenation, or an investor interested in backing foundational longevity science from an India-rooted healthtech founder—let's connect. We're building for the long arc.
Mahboob Hasan
Founder & CEO, Cosmyra Technologies Pvt. Ltd.
Initiator, EpochRevive